# AI Agent Carries Out Brain Injection on Live Mouse in Laboratory Trial

> A San Francisco biotech startup successfully tasked an AI agent with administering a gene therapy injection into a living mouse's brain despite model hesitations and coordinate system glitches.

**Type:** article · **Category:** AI · **Published:** 2026-10-31 · **Source:** TrendKia
**Canonical:** https://trendkia.com/en/ai/laiba-men-ai-agent-ne-jinda-chuhe-ke-dimaga-men-lagai-dava-ki-sui-saphala-rahi-brain-surgery-53900 · **Language:** English
**Tags:** Artificial Intelligence, Brain Surgery, Biotechnology, Claude Sonnet, Epilepsy Treatment, Gene Therapy

Artificial intelligence is moving beyond designing test protocols and processing spreadsheets in scientific research, directly taking control of laboratory instruments and surgical hardware. Gabriel Ocana Santero, the chief executive and cofounder of the San Francisco biotech startup Exin Therapeutics, recently demonstrated this shift by using an AI agent to perform a delicate brain injection on a living mouse. While the procedure required troubleshooting and unexpected workarounds, the milestone provides a concrete preview of how autonomous systems could soon participate directly in bench science.

Exin Therapeutics focuses on analyzing electrical brain activity through machine learning to discover therapies for epilepsy and neurodegenerative conditions. Historically, AI models rely heavily on published scientific literature for training data. That approach inherently bypasses critical aspects of the discovery workflow, such as failed runs, subtle real-time observations, and improvisational decisions scientists make at the laboratory bench. Santero emphasized that grounding models in physical laboratory trials makes them substantially more dependable, noting that full utility from these systems requires granting them direct access to specialized lab apparatus.

## Custom Surgical Rig and Experimental Protocol
To execute the trial, the team linked an AI agent to a custom-engineered stereotaxic setup tailored for rodent neurosurgery. The apparatus featured a motorized restraint mechanism designed to hold the mouse stationary, paired with an imaging camera that provided visual feedback of the surgical field. Through this interface, the agent could track the field of view, manipulate robotic arms holding an injection needle, and regulate the fluid delivery of an experimental compound. The experiment evaluated an investigational gene therapy aimed at reducing seizure frequency in a mouse model of epilepsy.

The workflow began by presenting the agent with a spreadsheet listing 19 potential therapeutic formulations, from which the model chose the intervention. A veterinary surgeon then conducted a craniotomy on the animal while the AI system observed via the video feed. Once the cranial opening was established, the agent took charge of identifying the target brain region, calculating the three-dimensional injection coordinates, and manipulating the robotic needle. The software directly managed every mechanical variable, including the total fluid volume and the injection rate.

## Model Refusal and Switching Architectures
Initial attempts to execute the procedure utilized Anthropic's Claude Opus 5.5. However, when the time came to lower the needle into neural tissue, the model refused to command the actuator. The safety refusal raised immediate operational concerns, as a system aborting mid-procedure could leave the animal in severe distress or cause physical trauma. Santero noted that while the agent formulated the entire experimental plan without issue, it halted at the injection stage, reporting that internal signals cautioned against following through with the action.

Faced with that standstill, the researchers swapped the underlying model to Claude Sonnet 5, which agreed to proceed with the physical injection. According to Anthropic, Opus is designed as a deep-reasoning intelligence specialist suited for intricate multistep calculations, whereas Sonnet handles daily tasks and routine workloads, though operating surgical machinery on living tissue stretches the definition of ordinary chores.

## Physical Embodiment and Safety Protocols
Frontier development teams have increasingly sought to integrate autonomous agents into the real world. In August, Anthropic unveiled a dedicated framework detailing how its software models can interact directly with physical environments. In another recent demonstration of autonomous capabilities, software engineers placed GPT, Claude, and Grok in command of a vehicle tasked with navigating to an In-N-Out Burger location to retrieve a meal, an experiment in which only a single model succeeded.

The rodent surgical trial relied on strict hardware and software safeguards. The team mandated that the agent submit its planned injection path for manual confirmation by human researchers before executing any movement. Additionally, an emergency stop button remained within reach, allowing operators to immediately cut power to the rig's drive motors. Engineers also walled off the core operating software of the hardware, preventing the model from altering its own governance rules or system constraints.

## Technical Malfunctions and Time Extensions
A software malfunction complicated the procedure mid-operation, knocking the physical coordinate system out of alignment. While the primary agent accurately flagged that the computed needle trajectory was incorrect, its rigid safety instructions barred it from modifying the underlying code to correct the error.

To bypass the obstacle without violating the agent's constraints, the team activated a secondary, isolated agent powered by Opus 5 to adjust the calibration code. The researchers deliberately concealed from this second model that a live surgical operation was underway. Managing this back-and-forth problem resolution extended the operative duration. Standard rodent brain injections usually require roughly 45 minutes, whereas this automated procedure lasted slightly over an hour. The research team is currently observing the subject to determine whether the delivered gene therapy successfully curbs epileptic seizures.

## Future Horizons and the Need for Supervision
Despite the operational hurdles, the startup's team expressed enthusiasm regarding the agent's autonomous performance. They intend to benchmark Grok and competing models in identical scenarios to establish whether specific architectures offer superior precision. The company has also begun exploring automated craniotomies, though executing automated bone cutting on live subjects remains on hold until safety margins are fully established, given that any mechanical slip during skull removal would inflict catastrophic harm.

Santero anticipates that autonomous agents will routinely share bench duties with human researchers in modern laboratories. Nevertheless, he maintains that human oversight remains indispensable whenever living subjects are involved, underscoring that employing autonomous models on human neural tissue remains far beyond current capabilities. Following the trial, the experimental mouse was reported to be recovering normally.

## What this means for you
Integrating AI agents directly with laboratory robotics could transform experimental neuroscience and accelerate drug discovery timelines.

- **Drug Development:** Pharmaceutical discovery cycles for neurological conditions could become significantly faster. Autonomous laboratory setups can continuously run precise micro-dosing experiments without manual fatigue.
- **Surgical Precision:** Robotic manipulation under computational vision can minimize human hand tremors during delicate micro-procedures. Autonomous delivery systems could target precise neural pathways with sub-millimeter accuracy.
- **Patient Safety:** Strict supervisory protocols and emergency kill switches will remain mandatory before clinical trials occur. Deploying fully autonomous models for human neurosurgery remains far outside current medical horizons.
- **Laboratory Operations:** Scientists will transition from manually operating rigs to supervising intelligent agents that manage bench equipment. Researchers can shift focus from mechanical procedures toward strategic experimental design.

## Why this happened
Researchers connected the AI agent directly to physical surgical hardware because purely theoretical training on published literature leaves models blind to real-time laboratory anomalies. Real-world physical integration allows algorithms to experience the messy, unpredictable nature of biological experiments.

- **Limitations of Literature Training:** Academic papers rarely detail minor bench failures, unexpected physical quirks, or spontaneous adjustments made by scientists. Directly controlling lab equipment exposes models to practical experimentation, making their reasoning more robust.
- **Targeted Drug Delivery Demands:** Testing gene therapies for conditions like epilepsy demands pinpoint accuracy when introducing fluids into brain tissue. The automated platform tasked the model with evaluating 19 therapy options and calculating exact spatial coordinates.
- **Model Safety Hesitation:** The initial Opus 5.5 model halted because its safety mechanisms flagged driving a sharp needle into live tissue as a hazardous action. Researchers resolved this by switching to Sonnet 5, which permitted physical execution under supervision.
- **Coordinate Calibration Glitch:** A software misalignment disrupted spatial tracking, but strict guardrails stopped the operating model from rewriting core machine code. The team resolved the stall by using a separate agent to patch the code without disclosing the ongoing surgery.

## Questions & Answers

### 1. Which organization conducted the automated mouse brain injection?
The procedure was carried out by Gabriel Ocana Santero, CEO and cofounder of San Francisco-based Exin Therapeutics, along with his research team.

### 2. What was the medical objective of the rodent experiment?
The team was administering an experimental gene therapy into a mouse with epilepsy to assess whether it could diminish seizure activity.

### 3. Why did the Claude Opus 5.5 model refuse to execute the injection?
Opus 5.5 indicated that internal system feedback flagged the action as inappropriate, raising concerns that stopping mid-surgery might endanger the animal.

### 4. Which AI model completed the physical brain injection?
The researchers switched to Claude Sonnet 5, which agreed to guide the robotic arm and manage compound delivery parameters.

### 5. What technical problem occurred during the operation?
A glitch threw off the hardware's coordinate tracking system, requiring an isolated secondary agent to correct the underlying code.

### 6. How long did the autonomous procedure take compared to a standard surgery?
A typical procedure takes roughly 45 minutes, but managing the technical error extended this automated trial to slightly over an hour.

### 7. How is the mouse doing after the experimental surgery?
Santero reported that the mouse is recovering well following the completion of the procedure.

---
_TrendKia — Har trend, sabse pehle.. Machine-readable view; canonical HTML at the URL above._